Correction: Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies

Affiliations

• ¹ Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany. Franz.Schaefer@med.uni-heidelberg.de.
• ² Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
• ³ Department of Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
• ⁴ Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
• ⁵ Department of Pediatric Nephrology, Ghent University Hospital, Erknet Center, C4C Ghent, Belgium.
• ⁶ Department of Nephrology, Phoenix Children's Hospital, Phoenix, AZ, USA.
• ⁷ Department of Pediatric Nephrology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
• ⁸ Department of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
• ⁹ Bayer Hispania, S.L, Sant Joan Despi, Barcelona, Spain.
• ¹⁰ Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
• ¹¹ Bayer AG, Wuppertal, Germany.
• ¹² Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
• ¹³ Children's Mercy Kansas City, Kansas City, MO, USA.